The development of Tirzepatide , the powerful dual-action GLP-1 and GIP agonist, is revolutionizing how we treat obesity. Known by the brand name Mounjaro , this medication offers patients unprecedented results. As Mounjaro becomes officially available, many patients are weighing a critical choice: the brand name versus the compounded option. This choice revolves around compounded Tirzepatide cost  and availability, impacting your budget, convenience, and safety profile. Th

Your Clinic-Supervised Strategy for GLP-1 Side Effect Management Starting treatment with GLP-1 receptor agonists like Semaglutide  (Ozempic/Wegovy) and Tirzepatide  (Mounjaro/Zepbound) is an exciting step toward better health. These dual-acting medications are highly effective because they mimic natural gut hormones to slow gastric emptying, regulate appetite, and control blood sugar. However, it is this very mechanism—slowing down digestion—that causes the majority of initia